A detailed history of High Pines Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, High Pines Wealth Management, LLC holds 775 shares of AMGN stock, worth $217,054. This represents 0.34% of its overall portfolio holdings.

Number of Shares
775
Previous 875 11.43%
Holding current value
$217,054
Previous $235,000 5.11%
% of portfolio
0.34%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $25,570 - $28,845
-100 Reduced 11.43%
775 $223,000
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $87,460 - $108,583
-400 Reduced 31.37%
875 $235,000
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $428 - $506
2 Added 0.16%
1,275 $283,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $2,483 - $3,027
11 Added 0.87%
1,273 $307,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $69,807 - $78,729
-311 Reduced 19.77%
1,262 $284,000
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $2.3 Million - $2.56 Million
-9,953 Reduced 86.35%
1,573 $383,000
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $217,077 - $240,144
990 Added 9.4%
11,526 $2.79 Million
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $1.66 Million - $1.9 Million
-8,331 Reduced 44.16%
10,536 $2.37 Million
Q3 2021

Oct 13, 2021

BUY
$212.27 - $248.7 $583,317 - $683,427
2,748 Added 17.05%
18,867 $4.01 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $56,759 - $62,971
243 Added 1.53%
16,119 $3.93 Million
Q1 2021

Apr 09, 2021

BUY
$221.91 - $258.6 $1.63 Million - $1.9 Million
7,351 Added 86.23%
15,876 $3.95 Million
Q4 2020

Apr 09, 2021

BUY
$216.38 - $257.67 $1.84 Million - $2.2 Million
8,525 New
8,525 $1.96 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track High Pines Wealth Management, LLC Portfolio

Follow High Pines Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Pines Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Pines Wealth Management, LLC with notifications on news.